Asoprisnil (J867) is a selective progesterone receptor modulator. It can be used to treat progesterone sensitive myomata.
Investigated for use/treatment in uterine fibroids.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.